Paper7656502
Clinical pharmacokinetics of altretamine.
Damia G and 1 other. Clin Pharmacokinet, 1995. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Clinical pharmacokinetics of altretamine. Papers, record 7656502. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7656502
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Altretamine | Major topic |
| Administration, Oral | |
| Animals | |
| Biological Availability | |
| Dose-Response Relationship, Drug | |
| Humans | |
| Infusions, Parenteral | |
| Injections, Intravenous | |
| Molecular Structure |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6781746 | Phase I study of pentamethylmelamine. | Cancer Treat Rep | 1980 | https://conductscience.org/library/papers/6781746 | PubMed |
| 2 | 820422 | Hexamethylmelamine. An evaluation of its role in the therapy of cancer. | Cancer | 1976 | https://conductscience.org/library/papers/820422 | PubMed |
| 3 | 117725 | Gas chromatographic determination of hexamethylmelamine in mouse plasma. | Anal Biochem | 1979 | https://conductscience.org/library/papers/117725 | PubMed |
| 4 | 4953645 | Phase I study of hexamethylmelamine (NSC-13875). | Cancer Chemother Rep | 1965 | https://conductscience.org/library/papers/4953645 | PubMed |
| 5 | 6778613 | Early clinical trial of a 1-day intermittent schedule for pentamethylmelamine. | Cancer Treat Rep | 1980 | https://conductscience.org/library/papers/6778613 | PubMed |
| 6 | 6771004 | Comparative pharmacology of pentamethylmelamine and hexamethylmelamine in mice. | Cancer Res | 1980 | https://conductscience.org/library/papers/6771004 | PubMed |
| 7 | 6783296 | Phase I and pharmacological studies of pentamethylmelamine administered by 24-hour intravenous infusion. | Cancer Res | 1981 | https://conductscience.org/library/papers/6783296 | PubMed |
| 8 | 2104537 | Phase I and clinical pharmacological evaluation of a parenteral hexamethylmelamine formulation. | Cancer Res | 1990 | https://conductscience.org/library/papers/2104537 | PubMed |
| 9 | 407012 | Analogues of hexamethylmelamine. The anti-neoplastic activity of derivatives with enhanced water solubility. | Chem Biol Interact | 1977 | https://conductscience.org/library/papers/407012 | PubMed |
| 10 | 2114821 | In vitro cytotoxicity of hexamethylmelamine (HMM) and its derivatives. | Anticancer Res | 1990 | https://conductscience.org/library/papers/2114821 | PubMed |
| 11 | 6417431 | Rapid formation of N-hydroxymethylpentamethylmelamine by mitochondria from rat small intestinal epithelium. | Life Sci | 1983 | https://conductscience.org/library/papers/6417431 | PubMed |
| 12 | 6401219 | Role of N-methylolpentamethylmelamine in the metabolic activation of hexamethylmelamine. | Cancer Res | 1983 | https://conductscience.org/library/papers/6401219 | PubMed |
| 13 | 646928 | Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. | Br J Cancer | 1978 | https://conductscience.org/library/papers/646928 | PubMed |
| 14 | 4748436 | N-demethylation of the antineoplastic agent hexamethylmelamine by rats and man. | Cancer Res | 1973 | https://conductscience.org/library/papers/4748436 | PubMed |
| 15 | 1904306 | Hexamethylmelamine: pharmacology and mechanism of action. | Cancer Treat Rev | 1991 | https://conductscience.org/library/papers/1904306 | PubMed |
| 16 | 6807543 | Parenteral formulation of hexamethylmelamine potentially suitable for use in man. | Cancer Treat Rep | 1982 | https://conductscience.org/library/papers/6807543 | PubMed |
| 17 | 4414651 | Metabolism of hexamethylmelamine-ring-14C in rats and man. | Cancer Res | 1974 | https://conductscience.org/library/papers/4414651 | PubMed |
| 18 | 109196 | Variable oral absorption of hexamethylmelamine in man. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/109196 | PubMed |
| 19 | 6428738 | Predictive testing with the subrenal capsule assay. | Cancer Treat Rev | 1984 | https://conductscience.org/library/papers/6428738 | PubMed |
| 20 | 1905441 | Altretamine. | DICP | 1991 | https://conductscience.org/library/papers/1905441 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42504052 | Overcoming Radiation Resistance: Ferroptosis Induction to Sensitize Solid Tumors to Radiation Therapy. | Cancer Med | 2026 | https://conductscience.org/library/papers/42504052 | PubMed |
| 41599403 | Triazole and Pyrazole Hybrids of Electrophilic Natural Products as Promising Anticancer Agents. | Molecules | 2026 | https://conductscience.org/library/papers/41599403 | PubMed |
| 40867898 | Living on the Edge: ROS Homeostasis in Cancer Cells and Its Potential as a Therapeutic Target. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40867898 | PubMed |
| 40807439 | Efficient Approaches to the Design of Six-Membered Polyazacyclic Compounds-Part 1: Aromatic Frameworks. | Molecules | 2025 | https://conductscience.org/library/papers/40807439 | PubMed |
| 39224646 | FDA-approved drugs containing dimethylamine pharmacophore: a review of the last 50 years. | RSC Adv | 2024 | https://conductscience.org/library/papers/39224646 | PubMed |
| 38613722 | Deciphering Ferroptosis: From Molecular Pathways to Machine Learning-Guided Therapeutic Innovation. | Mol Biotechnol | 2025 | https://conductscience.org/library/papers/38613722 | PubMed |
| 38590214 | A guide to ferroptosis in cancer. | Mol Oncol | 2024 | https://conductscience.org/library/papers/38590214 | PubMed |
| 37833746 | A review on the research progress of traditional Chinese medicine with anti-cancer effect targeting ferroptosis. | Chin Med | 2023 | https://conductscience.org/library/papers/37833746 | PubMed |
| 37559994 | Ferroptosis, a new form of cell death: mechanisms, biology and role in gynecological malignant tumor. | Am J Cancer Res | 2023 | https://conductscience.org/library/papers/37559994 | PubMed |
| 32606298 | The interaction between ferroptosis and lipid metabolism in cancer. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32606298 | PubMed |
| 31936571 | Ferroptosis in Cancer Cell Biology. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/31936571 | PubMed |
| 31184303 | The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs. | Elife | 2019 | https://conductscience.org/library/papers/31184303 | PubMed |
| 29576720 | Synthesis, molecular docking, ctDNA interaction, DFT calculation and evaluation of antiproliferative and anti-Toxoplasma gondii activities of 2,4-diaminotriazine-thiazole derivatives. | Med Chem Res | 2018 | https://conductscience.org/library/papers/29576720 | PubMed |
| 15656694 | Interactions between antiretrovirals and antineoplastic drug therapy. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/15656694 | PubMed |
| 15568891 | Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy. | Clin Pharmacokinet | 2004 | https://conductscience.org/library/papers/15568891 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7656502
GET https://conductscience.org/api/papers/v1/7656502/references?page=2